TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.005

-1.3%

2:22 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (442)	5/26/2005 6:36:35 PM
From: tktrimbath	Read Replies (1) of 557

Keeping track of TGEN, DNDN, and GERN are enough for me. So you are on your own for CEGE. I forgot to mention that I continue to be impressed with Targeted's management, but good management isn't as crucial as good science, a well crafted trial, and luck. As the CEO said these diseases are complex. The treatment has to have the luck of not kicking off some unexpected system, or getting in its own way somehow. By the way, if they get 15% to 40% of a $7B market by 2011, then they easily have $1B in revenue. Take a price to sales of about 6 (magically pulled out of thin air) and there's a market cap of $6B. As I recall that is higher than today's market cap. Here's hoping.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next